Johnson & Johnson (JNJ): return on equity, 10 filed years
ROE at Johnson & Johnson was 32.9% in FY2025, the newest filed year. Across the 10 computed years from FY2016 it ranged from 2.2% (FY2017) to 51.1% (FY2023), with a median of 24.5%.
Tonight's figure on the company page: 32.9%, recomputed 2026-10-15. The table is each filed year on its own terms, with the formula below; the current figure may use trailing twelve months or, where the explainer says so, a different denominator.
Year by year
| Fiscal year | ROE | Read from |
|---|---|---|
| FY2016 | 23.5% | 10-K, filed 2017-02-27 |
| FY2017 | 2.2% | 10-K, filed 2018-02-21 |
| FY2018 | 25.6% | 10-K, filed 2019-02-20 |
| FY2019 | 25.4% | 10-K, filed 2020-02-18 |
| FY2020 | 23.3% | 10-K, filed 2021-02-22 |
| FY2021 | 28.2% | 10-K, filed 2022-02-17 |
| FY2022 | 23.4% | 10-K, filed 2023-02-16 |
| FY2023 | 51.1% | 10-K, filed 2024-02-16 |
| FY2024 | 19.7% | 10-K, filed 2025-02-13 |
| FY2025 | 32.9% | 10-K, filed 2026-02-11 |
How each year is computed
Net income / shareholders equity x 100
Each year is a ratio of lines in that year's filed annual report, with the nightly recompute's own rules for what counts as a filed line. Nothing is estimated, smoothed or filled in: a year that cannot be computed says why.
Read further
A computation on accounts filed with the SEC, not a recommendation and not advice. Past filings do not indicate future results. Risk disclaimer.